Literature DB >> 12023068

Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse.

Raffaella Isola1, Hailing Zhang, Anne-Marie Duchemin, Gopi A Tejwani, Norton H Neff, Maria Hadjiconstantinou.   

Abstract

We studied the changes of met-enkephalin (Met-Enk) content and preproenkephalin (PPE) mRNA in the striatum in a mouse model of nicotine abstinence. Nicotine, 2 mg/kg, s.c., was administered four times daily for 14 days and Met-Enk and PPE mRNA evaluated at various times (4-96 h) following drug discontinuation. Met-Enk, assayed by radioimmunoassay, was increased in the ventral (nucleus accumbens) but not dorsal (putamen/caudate) striatum, while PPE mRNA, assayed in whole striatum by Northern blotting was elevated. Both changes were seen early during withdrawal and lasted over 72 h. In situ hybridization revealed enhanced signal in the dorsal striatum, mostly laterally, and smaller increases in the rostral pole, core and shell of the nucleus accumbens. These observations indicate that during nicotine withdrawal, striatal enkephalinergic neurons undergo adaptative responses, which might contribute to the abstinence behavioral syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023068     DOI: 10.1016/s0304-3940(02)00240-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

2.  Influence of δ-opioid receptors in the behavioral effects of nicotine.

Authors:  Fernando Berrendero; Ainhoa Plaza-Zabala; Lola Galeote; África Flores; S Andreea Bura; Brigitte L Kieffer; Rafael Maldonado
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum.

Authors:  Raffaella Isola; Hailin Zhang; Gopi A Tejwani; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

Review 4.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

5.  Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.

Authors:  K J Jackson; Frank Ivy Carroll; S S Negus; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

6.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

Review 7.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

8.  Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.

Authors:  Emily B Nuechterlein; Lisong Ni; Edward F Domino; Jon-Kar Zubieta
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-17       Impact factor: 5.067

Review 9.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

Review 10.  Tobacco/nicotine and endogenous brain opioids.

Authors:  Yue Xue; Edward F Domino
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-12-23       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.